NCR2 and acute lymphoblastic leukemia: The findings from our study suggest that Poly I:C, R848, and ODN may restore effectively the activation capacity of NK cells of ALL patients since the observed increase in NKp44 expression could reflect a heightened state of NK cell activation, potentially leading to improved cytotoxicity against tumor cells.